TL;DR
Get kitchen staples and gadgets delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A Sunday food safety roundup describes a sharp change in fortunes for cultivated meat companies: after attracting more than $2.5 billion in investment from 2021 through 2023, several startups shut down in 2025. The report points to funding challenges, costly manufacturing and uncertain commercial timelines, while leaving the sector’s longer-term prospects unresolved.
Several cultivated-meat startups shut down in 2025, marking a sharp reversal for a sector that attracted more than $2.5 billion in investment from 2021 through 2023, according to a Sunday Edition report from Food Safety News. The closures highlight the difficulty of turning cell-grown meat into a commercial business, though the report does not establish that the entire industry has abandoned development.
The report describes a funding boom that gathered pace as investors backed companies developing meat and seafood from animal cells. The Good Food Institute reported that cultivated meat and seafood firms drew more than $2.5 billion between 2021 and 2023; the report says the total was likely an underestimate because investment was moving quickly. In 2023, about half of venture capital in the sector went to five companies: Upside Foods, Believer Meats, Wildtype, Aleph Farms and Mosa Meat.
The subsequent closures included Netherlands-based Meatable, which ceased operations in late 2025, and British company CellRev, which said it could not meet commercial milestones in time to secure investment. Dutch startup Upstream Foods, which was developing cultivated fish fat, also shut down after failing to raise the capital it needed, the report says.
The report describes Believer Meats as a particularly prominent setback. The company completed a $125 million plant near Raleigh, North Carolina, in a 200,000-square-foot facility equipped with bioreactors and centrifuges. It had received U.S. government approval, but the report says the company lost a major financial backer and could not secure a last-minute loan. Believer Meats then ceased operations before producing any product, leaving the facility unused.
Why the Scale-Up Is Stalling
The closures matter because they show the gap between a technology’s scientific promise and the demands of producing food at commercial scale. Cultivated meat depends on specialized equipment and inputs, and the report identifies high energy needs, expensive bioreactors and nutrient solutions as major cost pressures. A large factory can represent substantial investment without demonstrating that production can be sustained at a price or volume that supports a business.
The funding downturn also changes the near-term outlook for consumers and workers. A company closure can halt a product’s path to market and leave purpose-built facilities unused. For investors, the setbacks point to a mismatch between venture funds’ typical five-to-seven-year return horizon and the report’s assessment that commercial viability may remain at least a decade away. That timeline is presented as an expectation, not a guaranteed forecast.
As an affiliate, we earn on qualifying purchases.
From Funding Boom to Closures
Cultivated meat is made by growing animal cells in a controlled environment rather than raising an animal for its meat. The report describes a process in which cells are collected from a living animal, placed in a growth medium and cultivated in a bioreactor, with the aim of producing food resembling conventional meat. The concept has been discussed for decades: it cites a 1931 essay by Winston Churchill imagining chicken parts grown separately.
Investment accelerated in the years before the recent closures. The report says government-linked sovereign wealth funds, traditional venture investors and major meat companies, including Tyson Foods and JBS, invested in the field. The expectation that products could reach consumers soon has since given way to a more difficult picture, as some companies failed to raise further capital or reach commercial milestones in time.
The source also places the cultivated-meat discussion within a broader food safety roundup. Other items included Taylor Farms’ plans to suspend harvesting and processing iceberg lettuce from Central Mexico for U.S. and Canadian sale during the May-to-August Cyclospora season, and an FDA 10-point plan to reduce future Cyclospora outbreaks. Those developments are separate from the cultivated-meat company closures.
“Cultured meat and seafood companies attracted over $2.5 billion in investment from 2021 through 2023.”
— Food Safety News, summarizing the Good Food Institute’s investment figures
cell culture equipment for food production
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unknown About Viability
The report does not provide a complete account of which cultivated-meat companies remain active, how much funding the surviving firms have, or whether they have revised their production plans. It also does not give current cost-per-unit figures, a confirmed date for broad commercial availability, or evidence that any specific production method can meet price and volume expectations.
The closures are evidence of setbacks at particular companies, not proof that cultivated meat as a whole cannot be produced commercially. The report’s estimate that viability may be a decade or more away is not tied to a named forecast or a specified definition of viability. It is also unclear whether companies that remain in the field can secure the capital and manufacturing capacity needed to reach their next milestones.
As an affiliate, we earn on qualifying purchases.
Funding and Production Milestones
The report does not identify a scheduled industry announcement or a single next milestone. The next indicators to watch are whether operating companies can raise additional funding, meet technical and commercial targets, and demonstrate production at a scale that can support a viable business. Any claims about timing will need to be tested against those results rather than treated as a confirmed launch schedule.
For now, the sector’s outlook remains unsettled: some prominent projects have ended, while the report does not say that all development has stopped. Further company disclosures, investment data and evidence of commercial production would help clarify whether cultivated meat can move beyond costly pilot and factory plans.
industrial bioreactors for food manufacturing
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What happened to cultivated-meat companies in 2025?
Food Safety News reports that several startups closed, including Meatable, CellRev, Upstream Foods and Believer Meats. Their stated or reported challenges included difficulty securing investment and meeting commercial milestones.
How much investment did the sector attract?
The Good Food Institute reported more than $2.5 billion invested from 2021 through 2023 in cultivated meat and seafood companies. The report says this total may be an underestimate; it does not give a different confirmed figure.
Why are cultivated-meat businesses facing financial pressure?
The report cites the high costs of bioreactors, energy and specialized nutrient solutions, along with the difficulty of raising capital before reaching commercial milestones. It also says venture investors often seek returns within five to seven years, while commercial viability may take longer.
Did Believer Meats produce cultivated chicken at its North Carolina plant?
No. The report says Believer Meats ceased operations before producing any product, despite completing its 200,000-square-foot facility near Raleigh.
Does the report show that cultivated meat is no longer being developed?
No. It reports multiple company closures but does not say that all cultivated-meat development has ended. The status, funding and timelines of other companies are not detailed.
Source: rss
Columbus Day / Indigenous Peoples' Day Picks
long weekend sales
As an affiliate, we earn on qualifying purchases.
